ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FENC Fennec Pharmaceuticals Inc

9.23
0.13 (1.43%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Fennec Pharmaceuticals Inc FENC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.13 1.43% 9.23 08:00:52
Open Price Low Price High Price Close Price Previous Close
9.23 9.15 9.38 9.23 9.10
more quote information »

Recent News

Date Time Source Heading
21/3/202421:00GLOBEFennec Pharmaceuticals Reports Full Year and Fourth Quarter..
19/3/202421:01GLOBEFennec Pharmaceuticals to Report Full Year and Fourth..
18/3/202418:00PRNUSFennec Pharmaceuticals and Norgine Enter into Exclusive..
18/3/202412:00GLOBEFennec Pharmaceuticals and Norgine Enter into Exclusive..
07/3/202408:07EDGAR2Form 8-K/A - Current report: [Amend]
01/3/202408:04EDGAR2Form 8-K - Current report
29/2/202423:04GLOBEFennec Pharmaceuticals Reports Preliminary Unaudited Net..
15/2/202402:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202421:55GLOBEFDA Issues Reminder of Non-Substitution of PEDMARKĀ® (sodium..
06/1/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:45EDGAR2Form 144 - Report of proposed sale of securities
05/1/202408:42EDGAR2Form 144 - Report of proposed sale of securities
30/12/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202307:51EDGAR2Form 144 - Report of proposed sale of securities
18/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
05/12/202321:55GLOBEFennec Announces Incremental $5 Million Investment from..
17/11/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202308:56EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202308:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:50GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
10/11/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202310:19EDGAR2Form 144 - Report of proposed sale of securities
06/11/202321:59GLOBEFennec Pharmaceuticals Announces Third Quarter 2023..
04/11/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:45GLOBEFennec Pharmaceuticals to Report Third Quarter 2023..
07/9/202319:59GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
08/8/202307:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202300:51EDGAR2Form 8-K/A - Current report: [Amend]
05/8/202300:58EDGAR2Form 8-K - Current report
05/8/202300:57EDGAR2Form 8-K - Current report
03/8/202319:59GLOBEFennec Pharmaceuticals Announces Second Quarter 2023..
31/7/202319:30GLOBEFennec Pharmaceuticals to Report Second Quarter 2023..
01/7/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202307:00GLOBEFennec Announces Results of Annual Meeting
06/6/202319:44GLOBEFennec Pharmaceuticals Announces European Commission..
11/5/202320:01GLOBEFennec Pharmaceuticals Announces First Quarter 2023..
08/5/202320:15GLOBEFennec Pharmaceuticals to Report First Quarter 2023..

Your Recent History

Delayed Upgrade Clock